Detection of congenital heart disease in the first trimester of pregnancy

Progress in Pediatric Cardiology

Volumn 22, Issue 1, 2006, Pages 3-8

  Bebbington, Michael ^a   Wilson, R Douglas ^a   Johnson, Mark P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ductus venosus; Early fetal echocardiography; First trimester imaging; Nuchal translucency

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; DUCTUS VENOSUS; ECHOCARDIOGRAPHY; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; KARYOTYPE; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL;

EID: 33645939539     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2006.01.001     Document Type: Article

References (34)

1. Allan L.D., Crawford D.C., Chita S.K., and Tynan M.J. Prenatal screening for congenital heart disease. Br Med J 282 (1986) 1717-1719
2. Tegnander E., Eik-Nes S.H., Johansen O.J., and Linker D.T. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 5 (1995) 372-380
3. Crane J.P., LeFevre M.L., Winborn R.C., et al. A randomized trial of prenatal ultrasonography screening: impact on the detection, management and outcome of anomalous fetuses. Am J Obstet Gynecol 171 (1994) 392-399
4. Hoffman J.I., and Christian R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 42 (1978) 641-647
5. Hyett J., Perdu M., Sharland G.K., Snijders R., and Nicolaides K.H. Using fetal nuchal translucency to screen for major congenital heart defects at 10-14 weeks of gestation: population based cohort study. Br Med J 318 (1999) 81-85
6. Souka A.P., Krample E., Bakalis S., Heath V., and Nicolaides K.H. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18 (2001) 9-17
7. Dugoff L., et al., for the FASTER Trial Research Consortium. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). Am J Obstet Gynecol 191 (2004) 1446-1451
8. Hyett J., Moscosco G., and Nicolaides K.H. Cardiac defects in 1st trimester fetus with trisomy 18. Fetal Diagn Ther 10 (1995) 381-386
9. Zosmer N., Souter V.L., Chan C.S., Huggon I.C., and Nicolaides K.H. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 106 (1999) 829-833
10. Bahado-Singh R.O., et al., for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Elevated first-trimester nuchal translucency increases the risk of congenital heart disease. Am J Obstet Gynecol 192 (2005) 1357-1361
11. Hyett J., Moscoso G., Pappanagiotou G., Perdu M., and Nicolaides K.H. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7 (1996) 245-250
12. Hyett J., Perdu M., Sharland G.K., Snijders R.S.M., and Nicolaides K.H. Increased nuchal translucency at 10-14 weeks of gestation ass a marker for major cardiac defects. Ultrasound Obstet Gynecol 10 (1997) 242-246
13. Simpson J.M., and Sharland G.K. Nuchal translucency and congenital heart defects: heart failure or not?. Ultrasound Obstet Gynecol 16 (2000) 30-36
14. Haddow J.E., Palomaki G.E., Knight G.J., Williams J., Miller W.A., and Johnson A. Screening of maternal serum for fetal Down syndrome in the first trimester. N Engl J Med 338 (1998) 955-961
15. Monni G., Zoppi M., Ibba R.M., and Floris M. Results of measurement of nuchal translucency ultrasound before and after training. Lancet 350 (1997) 1631
16. Mavrides E., Cobain-Sanchez F., Tekay A., et al. Limitations of using first-trimester muchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 17 (2001) 106-110
17. Makrydimas G., Sotiriadis A., and Ioannidids J.P. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 189 (2003) 1330-1335
18. Ghi T., Huggon C., Zosmer N., and Nicolaides K.H. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 18 (2001) 610-614
19. Iscrin L., Lonalay P., Viot G., et al. Prevalence of the microdeletion 22q11 in newborn infarcts with congenital conotruncal cardiac anomalies. Eur J Pediatr 157 (1998) 881-884
20. Hollis B., Mavrides E., Carvalho J.S., Hill L., Dickinson V., and Thilaganathan B. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency. Ultrasound Obstet Gynecol 18 (2001) 32-34
21. Montenegro N., Matias A., Areias J.C., Castedo S., and Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 10 (1997) 265-268
22. Matias A., Gomes C., Flack N., Montenegro N., and Nicolaides K.H. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 12 (1998) 380-384
23. Matias A., Huggon I., Areias J.C., Montenegro N., and Nicolaides K.H. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 14 (1999) 307-310
24. Favre R., Cherif Y., Kohler M., et al. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 21 (2003) 239-243
25. Borrell A., Antolin E., Costa D., Farre M.T., Martinez J.M., and Fortuny A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 179 (1998) 1612-1617
26. Mavrides E., Holden D., Bland J.M., Tekay A., and Thilaganathan B. Intraobserver and interobserver variability of transabdominal Doppler measurements of the fetal ductus venosus between 10 and 14 weeks of gestation. Ultrasound Obstet Gynecol 17 (2001) 306-310
27. Gembruch U., Knopfle G., Chatterjee M., Bald R., and Hansmann M. First trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol 75 (1990)
28. Dolkart L.A., and Reimers F.T. Transvaginal fetal echocardiography in early pregnancy: normative data. Am J Obstet Gynecol 165 (1991) 688-691
29. Bronshtein M., Zimmer E.Z., Milo S., Ho S.Y., Lorber A., and Gerlis L.M. Fetal cardiac abnormalities detected by transvaginal sonography at 12-16 weeks gestation. Obstet Gynecol 78 (1991) 374-378
30. Rustico M.A., Benettoni A., D'Ottavio G., et al. Early screening for fetal cardiac anomalies by transvaginal echocardiography is an unselected population: the role of operator experience. Ultrasound Obstet Gynecol 16 (2000) 614-619
31. Bronshtein M., and Zimmer E. The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol 19 (2002) 360-365
32. Gabriel C.C., Galindo A., Martinez J.M., et al. Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn 22 (2002) 586-593
33. Haak M.C., Twisk J., and Van Vugy J.M.G. How successful is fetal echocardiographic examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol 20 (2002) 9-13
34. Huggon I.C., Ghi T., Cook A.C., Zosmer N., Allen L.D., and Nicolaides K.H. Fetal cardiac anomalies identified prior to 14 weeks gestation. Ultrasound Obstet Gynecol 20 (2002) 22-29